Does Prescription Drug Adherence Reduce Hospitalizations and Costs?
William Encinosa; Didem Bernard; Avi Dor;
jel: jel:H51 | jel:I11
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence a... View more
Baum, C., Shaffer, M. and Stillman, S. (2003), “Instrumental Variables and GMM: Estimation and Testing.” The Stata Journal, Vol. 3 No. 1, pp. 1-31.
Becker, S. and Ichino, A. (2002), “Estimation of Average Treatment Effects Based on Propensity Scores.” The Stata Journal, Vol. 2 No. 4, pp. 358-377.
Bradford, D. et al. (2006), “Effects of Direct-to-Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductiase Inhibitors on Attainment of LDL-C Goals”, Clinical Therapeutics, Vol. 23 No. 12, pp. 2105-18.
Dezii, C.M. (2000), “Medication Noncompliance: What is the Problem?”, Managed Care, Vol. 9 No. 9, pp. 7-12.
Dor, A. (2004), “Optimal Price Rules, Administered Prices and Suboptimal Prevention: Evidence from a Medicare Program”, Journal of Regulatory Economics, Vol. 25 No. 1, pp. 81-104.
Dor, A. and Encinosa, W. (2004), “Does Cost-Sharing Affect Compliance? The Case of Prescription Drugs”, National Bureau of Economic Research Working Paper 10738, September, 2004. NBER: Cambridge, MA.
Dor, A. and Encinosa, W. (2010), “How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs. Journal of Economics and Management Strategy, 19:3 forthcoming.
Fendrick, A.M., Smith, D.G., Chernew, M.E., et al. (2001), “A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost”, American Journal of Managed Care, Vol. 7 No. 9, pp. 861-867.
Frank, R.G. and Newhouse, J.P. (2008), “Should Drug Prices Be Negotiated Under Part D of Medicare? And If So, How?”, Health Affairs, Vol. 27 No. 1, pp. 33-42.
Fuhrmans, V. (2004), “A Radical Prescription”, Wall Street Journal, May, 10, 2004. pp.